Salsolinol induced apoptotic changes in neural stem cells: Amelioration by neurotrophin support

NeuroToxicology

Volumn 35, Issue 1, 2013, Pages 50-61

  Shukla, A ^a,b   Mohapatra, T M ^b   Agrawal, A K ^a   Parmar, D ^a   Seth, K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Akt; Apoptosis; Neurotrophins; NSCs; Parkinson's; Salsolinol

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; NEUROTROPHIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SALSOLINOL;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL FATE; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME DEGRADATION; FETUS; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEURAL STEM CELL; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; OLFACTORY ENSHEATHING CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3; IN SITU NICK-END LABELING; ISOQUINOLINES; MITOCHONDRIA; NEURAL STEM CELLS; OLFACTORY BULB; PARACRINE COMMUNICATION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TIME FACTORS;

PARKINSONIA; RATTUS;

EID: 84872484225     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.12.005     Document Type: Article

References (64)

1. Amoureux M.C., Coulibaly B., Chinot O., Loundou A., Metellus P., Rougon G., Figarella-Branger D. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines. BMC Cancer 2010, 10:91.
2. Andereggen L., Meyer M., Guzman R., Ducray A.D., Widmer H.R. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease. Brain Res 2009, 1276:39-49.
3. Antkiewicz-Michaluk L., Krygowska-Wajs A., Szczudlik A., Romanska I., Vetulani J. Increase in salsolinol level in cerebrospinal fluid of Parkinsonian patients is related to dementia: advantage of new high-performance liquid chromatography methodology. Biol Psychiatry 1997, 42:514-518.
4. Bae O.N., Lee J.Y., Chung G.Y., Chung S.M., Lee M.Y., Yun Y.P., Kim Y.C., Moon C.K., Chung J.H. Enhanced menadione cytotoxicity in platelets isolated from streptozotocin-induced diabetic rats. Thromb Res 2003, 111:179-183.
5. Casalbore P., Barone I., Felsani A., D'Agnano I., Michetti F., Maira G., Cenciarelli C. Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways. J Cell Physiol 2010, 224:710-721.
6. Clodfelder-Miller B., De Sarno P., Zmijewska A.A., Song L., Jope R.S. Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. J Biol Chem 2005, 280:39723-39731.
7. Cova L., Armentero M.T., Zennaro E., Calzarossa C., Bossolasco P., Busca G., Lambertenghi Deliliers G., Polli E., Nappi G., Silani V., Blandini F. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res 2010, 1311:12-27.
8. Das J.R., Tizabi Y. Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells. Neurotox Res 2009, 16:194-204.
9. DeCuypere M., Lu Y., Miller D.D., LeDoux M.S. Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain. J Neurochem 2008, 107:1398-1413.
10. Deng Y., Luan Y., Qing H., Xie H., Lu J., Zhou J. The formation of catechol isoquinolines in PC12 cells exposed to manganese. Neurosci Lett 2008, 444:122-126.
11. Doncel-Pérez E., Caballero-Chacón S., Nieto-Sampedro M. Neurosphere cell differentiation to aldynoglia promoted by olfactory ensheathing cell conditioned medium. Glia 2009, 57:1393-1409.
12. Doetsch F., García-Verdugo J.M., Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 1997, 17:5046-5061.
13. Du K., Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 1998, 273:32377-32379.
14. Duncan M.W., Smythe G.A., Nicholson M.V., Clezy P.S. Comparison of high-performance liquid chromatography with electrochemical detection and gas chromatography-mass fragmentography for the assay of salsolinol, dopamine and dopamine metabolites in food and beverage samples. J Chromatogr 1984, 336:199-209.
15. Dworkin S., Malaterre J., Hollande F., Darcy P.K., Ramsay R.G., Mantamadiotis T. cAMP response element binding protein is required for mouse neural progenitor cell survival and expansion. Stem Cells 2009, 27:1347-1357.
16. Feng L., Meng H., Wu F., Cheng B., He X., Wang X., Li Z., Liu S. Olfactory ensheathing cells conditioned medium prevented apoptosis induced by 6-OHDA in PC12 cells through modulation of intrinsic apoptotic pathways. Int J Dev Neurosci 2008, 26:323-329.
17. Ge K.L., Chen W.F., Xie J.X., Wong M.S. Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways. J Ethnopharmacol 2010, 127:118-123.
18. Goldstein D.S., Sullivan P., Holmes C., Kopin I.J., Basile M.J., Mash D.C. Catechols in post-mortem brain of patients with Parkinson disease. Eur J Neurol 2011, 18:703-710.
19. Graham J.R., Tullai J.W., Cooper G.M. GSK-3 represses growth factor-inducible genes by inhibiting NF-kappaB in quiescent cells. J Biol Chem 2010, 285:4472-4480.
20. Islam O., Loo T.X., Heese K. Brain-Derived Neurotrophic Factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase AKT, and STAT-3 signaling pathways. Curr Neurovasc Res 2009, 6:42-53.
21. Kong P.J., Byun J.S., Lim S.Y., Lee J.J., Hong S.J., Kwon K.J., Kim S.S. Melatonin induces Akt phosphorylation through melatonin receptor- and PI3K-dependent pathways in primary astrocytes. Korean J Physiol Pharmacol 2008, 12:37-41.
22. Lee M.A., Lee H.S., Lee H.S., Cho K.G., Jin B.K., Sohn S., Lee Y.S., Ichinose H., Kim S.U. Over expression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins. Neurosci Lett 2002, 333:74-78.
23. Lee H.J., Kim M.K., Kim H.J., Kim S.U. Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model. PLoS One 2009, 4:e5586.
24. Li Q., Michaud M., Canosa S., Kuo A., Madri J.A. GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions. Angiogenesis 2011, 14:173-185.
25. Lim J., Yang C., Hong S.J., Kim K.S. Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: involvement of multiple transcription factors. Mol Cell Biochem 2000, 212:51-60.
26. Lin C.J., Tai Y., Huang M.T., Tsai Y.F., Hsu H.J., Tzen K.Y., Liou H.H. Cellular localization of the organic cation transporters OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem 2010, 114:717-727.
27. Lipson A.C., Widenfalk J., Lindqvist E., Ebendal T., Olson L. Neurotrophic properties of olfactory ensheathing glia. Exp Neurol 2003, 180:167-171.
28. Loberg R.D., Vesely E., Brosius F.C. Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J Biol Chem 2002, 277:41667-41673.
29. Lorenc-Koci E., Antkiewicz-Michaluk L., Kamińska A., Lenda T., Zieba B., Wierońska J., Smiałowska M., Schulze G., Rommelspacher H. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats. Neuroscience 2008, 156:973-986.
30. Majd S., Smardencas A., Parish C.L., Drago J. Development of an in vitro model to evaluate the regenerative capacity of adult brain-derived tyrosine hydroxylase-expressing dopaminergic neurons. Neurochem Res 2011, 36:967-977.
31. Malla R., Gopinath S., Alapati K., Gondi C.S., Gujrati M., Dinh D.H., Mohanam S., Rao J.S. Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One 2010, 5:e13731.
32. Maruyama W., Abe T., Tohgi H., Dostert P., Naoi M. A dopaminergic neurotoxin (R)-N-methylsalsolinol increases in parkinsonian cerebrospinal fluid. Ann Neurol 1996, 40:119-122.
33. Maruyama W., Dostert P., Matsubara K., Naoi M. N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Radic Biol Med 1995, 19:67-75.
34. Maruyama W., Nakahara D., Ota M., Takahashi T., Takahashi A., Nagatsu T., Naoi M. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study. J Neurochem 1992, 59:395-400.
35. Minami M., Takahashi T., Maruyama W., Takahashi A., Dostert P., Nagatsu T., Naoi M. Inhibition of tyrosine hydroxylase by R and S enantiomers of salsolinol, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. Neurochemistry 1992, 58:2097-2101.
36. Mine Y., Hayashi T., Yamada M., Okano H., Kawase T. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain. Neurosurgery 2009, 65:741-743.
37. Mravec B. Salsolinol a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments. Physiol Res 2006, 55:353-364.
38. Musshoff F., Schmidt P., Dettmeyer R., Priemer F., Wittig H., Madea B. A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas. Forensic Sci Int 1999, 105:1-11.
39. Nair V.D., Olanow CW Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses. J Biol Chem 2008, 283:15469-15478.
40. Naoi M., Maruyama W., Akao Y., Yi H. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. Neurotoxicol Teratol 2002, 24:579-591.
41. Naoi M., Maruyama W., Nagy G.M. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology 2004, 25:193-204.
42. Nguyen N., Lee S.B., Lee Y.S., Lee K.H., Ahn J.Y. Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 2009, 34:942-951.
43. Nishimura F., Yoshikawa M., Kanda S., Nonaka M., Yokota H., Shiroi A., Nakase H., Hirabayashi H., Ouji Y., Birumachi J., Ishizaka S., Sakaki T. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 2003, 212:171-180.
44. Pellitteri R., Spatuzza M., Russo A., Zaccheo D., Stanzani S. Olfactory ensheathing cells represent an optimal substrate for hippocampal neurons: an in vitro study. Int J Dev Neurosci 2009, 27:453-458.
45. Quesada A., Lee B.Y., Micevych P.E. PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev Neurobiol 2008, 68:632-644.
46. Salas T.R., Reddy S.A., Clifford J.L., Davis R.J., Kikuchi A., Lippman S.M., Menter D.G. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J Biol Chem 2003, 278:41338-41346.
47. Salinas M., Diaz R., Abraham N.G., Ruiz de., Galarreta C.M., Cuadrado A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem 2003, 278:13898-13904.
48. Scholz J., Klingemann I., Moser A. Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease. J Neurol Neurosurg Psychiatry 2004, 75:634-636.
49. Shukla S., Chaturvedi R.K., Seth K., Roy N.S., Agrawal A.K. Enhanced survival and function of neural stem cells-derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats. J Neurochem 2009, 109:436-451.
50. Stahl K., Mylonakou M.N., Skare O., Amiry-Moghaddam M., Torp R. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. Brain Res 2011, 1378:105-118.
51. Storch A., Kaftan A., Burkhardt K., Schwarz J. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res 2000, 855:67-75.
52. Strolin Benedetti M., Bellotti V., Pianezzola E., Moro E., Carminati P., Dostert P. Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm 1989, 77:47-53.
53. Takahashi T., Deng Y., Maruyama W., Dostert P., Kawai M., Naoi M. Uptake of a neurotoxin-candidate (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J Neural Transm 1994, 98:107-118.
54. Taubert D., Grimberg G., Stenzel W., Schömig E. Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons. PLoS One 2007, 2:e385.
55. Wang T.Y., Forsythe J.S., Nisbet D.R., Parish C.L. Promoting engraftment of transplanted neural stem cells/progenitors using biofunctionalised electrospun scaffolds. Biomaterials 2012, 33:9188-9197.
56. Wanpen S., Kooncumchoo P., Shavali S., Govitrapong P., Ebadi M. Salsolinol, an endogenous neurotoxin, activates JNK and NF-kappaB signaling pathways in human neuroblastoma cells. Neurochem Res 2007, 32:443-450.
57. Weng Z., Signore A.P., Gao Y., Wang S., Zhang F., Hastings T., Yin X.M., Chen J. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 2007, 282:34479-34491.
58. Xia Y., Wang C.Z., Liu J., Anastasio N.C., Johnson K.M. Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology 2010, 58:330-336.
59. Yang Z., Qiao H., Sun Z., Li X. Effect of BDNF-plasma-collagen matrix controlled delivery system on the behavior of adult rats neural stem cells. J Biomed Mater Res A 2012, 10.1002/jbm.a.34331.
60. Yi H., Akao Y., Maruyama W., Chen K., Shih J., Naoi M., Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells. J Neurochem 2006, 962:541-549.
61. Yuan H., Zhang Z.W., Liang L.W., Shen Q., Wang X.D., Ren S.M., Ma H.J., Jiao S.J., Liu P. Treatment strategies for Parkinson's disease. Neurosci Bull 2010, 26:66-76.
62. Zeng X., Chen J., Deng X., Liu Y., Rao M.S., Cadet J.L., Freed W.J. An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+toxicity and GDNF neuroprotection. Neuropsychopharmacology 2006, 31:2708-2715.
63. Zhang Y., Wang L., Mu X., Duan J., Zhu Y., Qing H., Li Y., Xiao S., Deng Y. Assessment of salsolinol N-methyltransferase activity in rat peripheral lymphocytes by liquid chromatography-electrospray time-of-flight mass spectrometry. Anal Bioanal Chem 2011, 399:3541-3545.
64. Zhao Y., Yao S., Wang S. Neural stem cell transplantation in the hippocampus of rats with cerebral ischemia/reperfusion injury Activation of the phosphatidylinositol-3 kinase/Akt pathway and increased brain-derived neurotrophic factor expression. Neural Regen Res 2010, 5:1605-1610.